サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1798905

ヘマトクリット測定装置の世界市場

Hematocrit Test Devices

出版日
ページ情報
英文 287 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.30円
ヘマトクリット測定装置の世界市場
出版日: 2025年08月27日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 287 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

ヘマトクリット測定装置の世界市場は2030年までに64億米ドルに到達

2024年に56億米ドルと推定されるヘマトクリット測定装置の世界市場は、分析期間2024-2030年にCAGR 2.4%で成長し、2030年には64億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである血液分析装置は、CAGR 2.8%を記録し、分析期間終了時には36億米ドルに達すると予測されます。ヘマトクリット測定器セグメントの成長率は、分析期間中CAGR 1.8％と推定されます。

米国市場は15億米ドル、中国はCAGR 4.8％で成長予測

米国のヘマトクリット測定装置市場は、2024年に15億米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGR4.8％を引きずる形で、2030年までに12億米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ0.9%と1.8%と予測されています。欧州では、ドイツがCAGR 1.3%で成長すると予測されています。

世界のヘマトクリット測定装置市場- 主要動向と促進要因まとめ

ヘマトクリット検査が臨床診断と患者モニタリングに不可欠な理由とは？

ヘマトクリット測定装置は、患者の血液中の赤血球の割合を測定し、貧血、脱水、多血症、出血などの状態に関する重要な洞察を提供します。これらの装置は、病院、外来診療所、救急部、血液銀行、在宅医療の現場で、日常的な血液分析や治療モニタリングの一環として使用されています。ヘマトクリット値は、酸素運搬能力の評価、血液疾患の診断、体液バランスの評価に不可欠です。この検査は、透析、化学療法、大手術を受けている患者に特に関連しており、赤血球量を定期的にモニタリングする必要があります。

検査機器には、検査室で使用される卓上型分析装置から、ベッドサイドや現場での使用に適した携帯型のポイントオブケア機器まで、さまざまなものがあります。検査室へのアクセスが限られている地域では、携帯型ヘマトクリット測定器は複雑なインフラを必要とせず、迅速で信頼性の高い結果を提供します。慢性疾患の増加や分散型診断モデルの拡大により、日常の臨床ワークフローや長期的な患者ケアにおけるヘマトクリット検査の役割が強化されています。

精度、スピード、アクセシビリティを向上させるテクノロジーとは？

最新のヘマトクリット測定装置では、赤血球量を測定するために微量遠心法、導電率測定法、光学検出法が使用されています。ポイント・オブ・ケア機器は、キャピラリー血液サンプルを使用することが多く、オペレーターのトレーニングは最低限で済み、高精度でほぼ瞬時の結果が得られます。光学センサー、使い捨て検査ストリップ、コンパクトな一体型分析装置の開発により、プライマリ・ケアや資源の限られた環境での幅広い展開が可能になりつつあります。

機器は現在、自動校正、リアルタイムの結果解釈、電子カルテとのデータ共有のための統合接続を特徴としています。バッテリー駆動や、ヘマトクリットとヘモグロビンやその他の血液指標を組み合わせたマルチパラメータ検査が可能なモデルもあります。試薬の安定性と小型化されたコンポーネントの進歩により、メーカー各社は装置の小型化とコスト削減を実現し、これらのシステムを移動診療所や在宅医療への応用を可能にしています。このような改良によって診断スピードが向上し、集中治療と遠隔治療の両方の環境での幅広い使用が可能になりつつあります。

どこで採用が拡大し、どのようなヘルスケア環境で使用が促進されているか？

ヘマトクリット値検査は、病院や専門クリニック、特に腎臓内科、腫瘍内科、血液内科で広く使用されています。献血センターや輸血サービスでは、ドナーの適格性や製品の品質を判断するためにヘマトクリット測定に依存しています。救急現場では、ヘマトクリット値は外傷の重症度や体液の状態を評価するのに役立ちます。農村部や低資源環境では、地域保健プログラム、妊産婦ケア、慢性疾患モニタリングに携帯型ヘマトクリット値が使用されるようになってきています。

在宅ヘルスケアでは、高齢患者の増加や個別化ケア管理へのシフトにより、採用が拡大しています。妊産婦ケアセンターでは母親の貧血をモニターするためにヘマトクリット検査が使用され、スポーツ医学の開業医はアスリートの赤血球量を評価します。地理的には、北米、欧州、そしてアジアやアフリカの新興ヘルスケアシステムで力強い成長が見られ、そこでは診断へのアクセス向上が公衆衛生の優先事項となっています。分散型診断やバリューベース医療を重視する医療機関では、臨床効率を向上させる費用対効果の高いツールとしてヘマトクリット測定装置が採用されています。

ヘマトクリット測定装置市場の成長はいくつかの要因によってもたらされる...

ヘマトクリット測定装置市場の成長は、慢性疾患の流行、診断の分散化、技術の小型化に関するいくつかの要因によって牽引されています。貧血、腎不全、がんの罹患率の増加により、入院患者や外来患者におけるヘマトクリット検査の頻度が増加しています。ポータブル分析装置、キャピラリーサンプリング技術、リアルタイムデータ統合の進歩は、ポイントオブケアの使いやすさと患者関与を向上させています。また、妊産婦健康プログラム、在宅医療プロトコル、移動式診断ユニットなどでの幅広い採用も成長を支えています。ヘルスケアシステムが早期診断と遠隔モニタリングを優先する中、ヘマトクリット測定装置は正確で迅速、かつ利用しやすい血液分析に不可欠なツールとなりつつあります。

セグメント

製品（血液分析装置、ヘマトクリット値測定器、その他製品）;エンドユーザー（病院／外来手術センター、クリニック、診断・病理ラボ、その他エンドユーザー）

調査対象企業の例

  • Abbott Laboratories
  • ACON Laboratories, Inc.
  • Beckman Coulter, Inc.（Danaher）
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Boule Diagnostics AB
  • Clindiag Systems
  • EKF Diagnostics Holdings plc
  • F. Hoffmann-La Roche Ltd.
  • Greiner Bio-One GmbH
  • HemoCue AB（a Danaher company）
  • Horiba Medical
  • IDEXX Laboratories, Inc.
  • Medonic AB
  • Mindray Bio-Medical Electronics
  • Nihon Kohden Corporation
  • OrSense, Ltd.
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP38900

Global Hematocrit Test Devices Market to Reach US$6.4 Billion by 2030

The global market for Hematocrit Test Devices estimated at US$5.6 Billion in the year 2024, is expected to reach US$6.4 Billion by 2030, growing at a CAGR of 2.4% over the analysis period 2024-2030. Blood Analyzers, one of the segments analyzed in the report, is expected to record a 2.8% CAGR and reach US$3.6 Billion by the end of the analysis period. Growth in the Hematocrit Test Meters segment is estimated at 1.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.5 Billion While China is Forecast to Grow at 4.8% CAGR

The Hematocrit Test Devices market in the U.S. is estimated at US$1.5 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2030 trailing a CAGR of 4.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.9% and 1.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.3% CAGR.

Global Hematocrit Test Devices Market - Key Trends & Drivers Summarized

Why Are Hematocrit Tests Critical to Clinical Diagnostics and Patient Monitoring?

Hematocrit test devices measure the proportion of red blood cells in a patient’s blood, offering critical insights into conditions such as anemia, dehydration, polycythemia, and blood loss. These devices are used in hospitals, outpatient clinics, emergency departments, blood banks, and home care settings as part of routine blood analysis and treatment monitoring. Hematocrit levels are essential for assessing oxygen-carrying capacity, diagnosing hematologic disorders, and evaluating fluid balance. The test is particularly relevant for patients undergoing dialysis, chemotherapy, or major surgery, where red cell volume needs regular monitoring.

Devices range from benchtop analyzers used in laboratories to portable, point-of-care devices suited for bedside or field use. In regions with limited laboratory access, portable hematocrit analyzers provide rapid, reliable results without the need for complex infrastructure. Increasing incidence of chronic diseases and the expansion of decentralized diagnostic models are reinforcing the role of hematocrit testing in everyday clinical workflows and long-term patient care.

How Are Technologies Advancing Accuracy, Speed, and Accessibility?

Modern hematocrit test devices use microcentrifugation, conductivity measurement, and optical detection methods to determine red blood cell volume. Point-of-care devices often use capillary blood samples and require minimal operator training, providing near-instantaneous results with high accuracy. Developments in optical sensors, disposable test strips, and compact integrated analyzers are enabling broader deployment in primary care and resource-limited environments.

Devices now feature automatic calibration, real-time result interpretation, and integrated connectivity for data sharing with electronic health records. Some models include battery-powered operation and multi-parameter testing, combining hematocrit with hemoglobin and other blood indices. Advances in reagent stability and miniaturized components are helping manufacturers reduce unit size and cost, making these systems viable for mobile clinics and home health applications. These improvements are enhancing diagnostic speed while supporting wider use in both centralized and remote care settings.

Where Is Adoption Growing and Which Healthcare Settings Are Driving Usage?

Hematocrit testing is widely used in hospitals and specialty clinics, particularly nephrology, oncology, and hematology departments. Blood donation centers and transfusion services rely on hematocrit measurement to determine donor eligibility and product quality. In emergency settings, hematocrit levels help assess trauma severity and fluid status. In rural and low-resource settings, portable hematocrit devices are increasingly used in community health programs, maternal care, and chronic disease monitoring.

Adoption is growing in home healthcare due to the rising number of elderly patients and the shift toward personalized care management. Prenatal care centers use hematocrit tests to monitor maternal anemia, while sports medicine practitioners evaluate red cell mass in athletes. Geographic growth is strong in North America, Europe, and emerging healthcare systems in Asia and Africa, where increased access to diagnostics is a public health priority. Institutions focusing on decentralized diagnostics and value-based care are adopting hematocrit test devices as cost-effective tools to improve clinical efficiency.

The Growth in the Hematocrit Test Devices Market Is Driven by Several Factors…

The growth in the hematocrit test devices market is driven by several factors related to chronic disease prevalence, decentralized diagnostics, and technology miniaturization. Rising incidence of anemia, renal failure, and cancer is increasing the frequency of hematocrit testing across inpatient and outpatient settings. Advancements in portable analyzers, capillary sampling techniques, and real-time data integration are improving point-of-care usability and patient engagement. Growth is also supported by broader adoption in maternal health programs, home care protocols, and mobile diagnostic units. As healthcare systems prioritize early diagnosis and remote monitoring, hematocrit test devices are becoming essential tools for accurate, rapid, and accessible blood analysis.

SCOPE OF STUDY:

The report analyzes the Hematocrit Test Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Blood Analyzers, Hematocrit Test Meters, Other Products); End-User (Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 47 Featured) -

  • Abbott Laboratories
  • ACON Laboratories, Inc.
  • Beckman Coulter, Inc. (Danaher)
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Boule Diagnostics AB
  • Clindiag Systems
  • EKF Diagnostics Holdings plc
  • F. Hoffmann-La Roche Ltd.
  • Greiner Bio-One GmbH
  • HemoCue AB (a Danaher company)
  • Horiba Medical
  • IDEXX Laboratories, Inc.
  • Medonic AB
  • Mindray Bio-Medical Electronics
  • Nihon Kohden Corporation
  • OrSense, Ltd.
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Hematocrit Test Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Anemia, Dehydration, and Blood Disorders Drives Demand for Hematocrit Testing in Clinical and Home Settings
    • Expansion of Point-of-Care Testing (POCT) Solutions Strengthens Market for Portable and Handheld Hematocrit Analyzers
    • Increased Adoption of Hematocrit Measurement in Pre-Surgical, Dialysis, and ICU Monitoring Enhances Clinical Integration
    • OEM Innovation in Micro-Sample and Capillary-Based Devices Improves Comfort and Accuracy in Pediatric and Geriatric Use
    • Growth in Blood Donation and Transfusion Services Spurs Routine Hematocrit Screening for Donor Eligibility and Safety
    • Technological Advancements in Optical and Centrifugal Measurement Techniques Expand Product Differentiation
    • Integration of Hematocrit Testing Into Multi-Parameter Hematology Devices Streamlines Workflow in Diagnostic Labs
    • Rising Demand for At-Home Monitoring by Chronic Kidney Disease (CKD) and Chemotherapy Patients Supports Telehealth Integration
    • Digital Connectivity Features in New Devices Enable Seamless Data Transfer to EHR and Patient Portals
    • Growing Need for Rapid, On-Site Results in Emergency and Mobile Clinics Fuels Demand for Lightweight, Battery-Operated Devices
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Hematocrit Test Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Hematocrit Test Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Hematocrit Test Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Hematocrit Test Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Blood Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Blood Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Blood Analyzers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Hematocrit Test Meters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Hematocrit Test Meters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Hematocrit Test Meters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals / Ambulatory Surgery Centers End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hospitals / Ambulatory Surgery Centers End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Hospitals / Ambulatory Surgery Centers End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Clinics End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Clinics End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Clinics End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Diagnostic & Pathology Labs End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Diagnostic & Pathology Labs End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Diagnostic & Pathology Labs End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Hematocrit Test Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Hematocrit Test Devices by Product - Percentage Breakdown of Value Sales for Blood Analyzers, Hematocrit Test Meters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Hematocrit Test Devices by End-user - Percentage Breakdown of Value Sales for Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Hematocrit Test Devices by Product - Percentage Breakdown of Value Sales for Blood Analyzers, Hematocrit Test Meters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Hematocrit Test Devices by End-user - Percentage Breakdown of Value Sales for Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • JAPAN
    • Hematocrit Test Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Hematocrit Test Devices by Product - Percentage Breakdown of Value Sales for Blood Analyzers, Hematocrit Test Meters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Hematocrit Test Devices by End-user - Percentage Breakdown of Value Sales for Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • CHINA
    • Hematocrit Test Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: China 16-Year Perspective for Hematocrit Test Devices by Product - Percentage Breakdown of Value Sales for Blood Analyzers, Hematocrit Test Meters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: China 16-Year Perspective for Hematocrit Test Devices by End-user - Percentage Breakdown of Value Sales for Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • EUROPE
    • Hematocrit Test Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Hematocrit Test Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Hematocrit Test Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Hematocrit Test Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Hematocrit Test Devices by Product - Percentage Breakdown of Value Sales for Blood Analyzers, Hematocrit Test Meters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Hematocrit Test Devices by End-user - Percentage Breakdown of Value Sales for Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • FRANCE
    • Hematocrit Test Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: France 16-Year Perspective for Hematocrit Test Devices by Product - Percentage Breakdown of Value Sales for Blood Analyzers, Hematocrit Test Meters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: France 16-Year Perspective for Hematocrit Test Devices by End-user - Percentage Breakdown of Value Sales for Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • GERMANY
    • Hematocrit Test Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Hematocrit Test Devices by Product - Percentage Breakdown of Value Sales for Blood Analyzers, Hematocrit Test Meters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Hematocrit Test Devices by End-user - Percentage Breakdown of Value Sales for Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Hematocrit Test Devices by Product - Percentage Breakdown of Value Sales for Blood Analyzers, Hematocrit Test Meters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Hematocrit Test Devices by End-user - Percentage Breakdown of Value Sales for Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Hematocrit Test Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Hematocrit Test Devices by Product - Percentage Breakdown of Value Sales for Blood Analyzers, Hematocrit Test Meters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Hematocrit Test Devices by End-user - Percentage Breakdown of Value Sales for Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Hematocrit Test Devices by Product - Percentage Breakdown of Value Sales for Blood Analyzers, Hematocrit Test Meters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: Spain 16-Year Perspective for Hematocrit Test Devices by End-user - Percentage Breakdown of Value Sales for Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Hematocrit Test Devices by Product - Percentage Breakdown of Value Sales for Blood Analyzers, Hematocrit Test Meters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: Russia 16-Year Perspective for Hematocrit Test Devices by End-user - Percentage Breakdown of Value Sales for Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Hematocrit Test Devices by Product - Percentage Breakdown of Value Sales for Blood Analyzers, Hematocrit Test Meters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Hematocrit Test Devices by End-user - Percentage Breakdown of Value Sales for Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Hematocrit Test Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Hematocrit Test Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Hematocrit Test Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Hematocrit Test Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Hematocrit Test Devices by Product - Percentage Breakdown of Value Sales for Blood Analyzers, Hematocrit Test Meters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Hematocrit Test Devices by End-user - Percentage Breakdown of Value Sales for Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Hematocrit Test Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Hematocrit Test Devices by Product - Percentage Breakdown of Value Sales for Blood Analyzers, Hematocrit Test Meters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 115: Australia 16-Year Perspective for Hematocrit Test Devices by End-user - Percentage Breakdown of Value Sales for Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • INDIA
    • Hematocrit Test Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 118: India 16-Year Perspective for Hematocrit Test Devices by Product - Percentage Breakdown of Value Sales for Blood Analyzers, Hematocrit Test Meters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 121: India 16-Year Perspective for Hematocrit Test Devices by End-user - Percentage Breakdown of Value Sales for Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Hematocrit Test Devices by Product - Percentage Breakdown of Value Sales for Blood Analyzers, Hematocrit Test Meters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 127: South Korea 16-Year Perspective for Hematocrit Test Devices by End-user - Percentage Breakdown of Value Sales for Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Hematocrit Test Devices by Product - Percentage Breakdown of Value Sales for Blood Analyzers, Hematocrit Test Meters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Hematocrit Test Devices by End-user - Percentage Breakdown of Value Sales for Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Hematocrit Test Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Hematocrit Test Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Hematocrit Test Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Hematocrit Test Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Hematocrit Test Devices by Product - Percentage Breakdown of Value Sales for Blood Analyzers, Hematocrit Test Meters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Hematocrit Test Devices by End-user - Percentage Breakdown of Value Sales for Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Hematocrit Test Devices by Product - Percentage Breakdown of Value Sales for Blood Analyzers, Hematocrit Test Meters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 148: Argentina 16-Year Perspective for Hematocrit Test Devices by End-user - Percentage Breakdown of Value Sales for Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Hematocrit Test Devices by Product - Percentage Breakdown of Value Sales for Blood Analyzers, Hematocrit Test Meters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 154: Brazil 16-Year Perspective for Hematocrit Test Devices by End-user - Percentage Breakdown of Value Sales for Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Hematocrit Test Devices by Product - Percentage Breakdown of Value Sales for Blood Analyzers, Hematocrit Test Meters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 160: Mexico 16-Year Perspective for Hematocrit Test Devices by End-user - Percentage Breakdown of Value Sales for Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Hematocrit Test Devices by Product - Percentage Breakdown of Value Sales for Blood Analyzers, Hematocrit Test Meters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 16-Year Perspective for Hematocrit Test Devices by End-user - Percentage Breakdown of Value Sales for Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Hematocrit Test Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Hematocrit Test Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Hematocrit Test Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Hematocrit Test Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Hematocrit Test Devices by Product - Percentage Breakdown of Value Sales for Blood Analyzers, Hematocrit Test Meters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Hematocrit Test Devices by End-user - Percentage Breakdown of Value Sales for Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Hematocrit Test Devices by Product - Percentage Breakdown of Value Sales for Blood Analyzers, Hematocrit Test Meters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 181: Iran 16-Year Perspective for Hematocrit Test Devices by End-user - Percentage Breakdown of Value Sales for Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Hematocrit Test Devices by Product - Percentage Breakdown of Value Sales for Blood Analyzers, Hematocrit Test Meters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 187: Israel 16-Year Perspective for Hematocrit Test Devices by End-user - Percentage Breakdown of Value Sales for Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Hematocrit Test Devices by Product - Percentage Breakdown of Value Sales for Blood Analyzers, Hematocrit Test Meters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 16-Year Perspective for Hematocrit Test Devices by End-user - Percentage Breakdown of Value Sales for Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Hematocrit Test Devices by Product - Percentage Breakdown of Value Sales for Blood Analyzers, Hematocrit Test Meters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 199: UAE 16-Year Perspective for Hematocrit Test Devices by End-user - Percentage Breakdown of Value Sales for Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Hematocrit Test Devices by Product - Percentage Breakdown of Value Sales for Blood Analyzers, Hematocrit Test Meters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 16-Year Perspective for Hematocrit Test Devices by End-user - Percentage Breakdown of Value Sales for Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • AFRICA
    • Hematocrit Test Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Hematocrit Test Devices by Product - Percentage Breakdown of Value Sales for Blood Analyzers, Hematocrit Test Meters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 211: Africa 16-Year Perspective for Hematocrit Test Devices by End-user - Percentage Breakdown of Value Sales for Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users for the Years 2014, 2025 & 2030

IV. COMPETITION